Sphera Funds Management’s Dova Pharmaceuticals DOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-185,000
Closed -$1.4M – 135
2018
Q4
$1.4M Buy
185,000
+65,000
+54% +$1.05M 0.16% 83
2018
Q3
$2.52M Buy
+120,000
New +$2.86M 0.29% 80
2017
Q4
– Sell
-78,284
Closed -$1.9M – 161
2017
Q3
$1.9M Sell
78,284
-16,716
-18% -$396K 0.27% 88
2017
Q2
$2.12M Buy
+95,000
New +$2M 0.36% 81

Other funds holding DOVA

Sphera Funds Management's DOVA Position: Q1 2019 in Review

Sphera Funds Management sold out of Dova Pharmaceuticals (DOVA) in Q1 2019, closing a stake of 185,000 shares — an estimated $1.4M sold.

Sphera Funds Management first reported a position in DOVA in Q2 2017 and held it in 4 quarters. The position peaked at $2.52M in Q3 2018. 59 funds tracked by Wall St. Rank hold DOVA as of Q1 2019.

  • Sphera Funds Management reported no remaining Dova Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Sphera Funds Management sold 185,000 Dova Pharmaceuticals shares in Q1 2019, an estimated $1.4M.
  • Sphera Funds Management first reported a position in Dova Pharmaceuticals in Q2 2017 and held it in 4 quarters.
  • Sphera Funds Management's Dova Pharmaceuticals position peaked at $2.52M in Q3 2018.
  • 59 funds tracked by Wall St. Rank held Dova Pharmaceuticals as of Q1 2019.

Based on Sphera Funds Management's 13F filing for Q1 2019, filed 15 May 2019.